A detailed history of Western Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Western Wealth Management, LLC holds 19,979 shares of BMY stock, worth $1.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
19,979
Previous 23,758 15.91%
Holding current value
$1.15 Million
Previous $986,000 4.77%
% of portfolio
0.06%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $149,875 - $195,563
-3,779 Reduced 15.91%
19,979 $1.03 Million
Q2 2024

Jul 19, 2024

SELL
$40.25 - $52.99 $102,436 - $134,859
-2,545 Reduced 9.68%
23,758 $986,000
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $560,454 - $635,446
11,681 Added 79.89%
26,303 $1.43 Million
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $157,947 - $188,475
-3,258 Reduced 18.22%
14,622 $750,000
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $166,781 - $186,487
-2,881 Reduced 13.88%
17,880 $1.04 Million
Q2 2023

Aug 30, 2023

SELL
$63.71 - $70.74 $71,546 - $79,441
-1,123 Reduced 5.13%
20,761 $1.33 Million
Q1 2023

Aug 30, 2023

SELL
$65.71 - $74.53 $72,543 - $82,281
-1,104 Reduced 4.8%
21,884 $1.52 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $1.48 Million - $1.76 Million
-21,646 Reduced 48.5%
22,988 $1.65 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $1,395 - $824,646
10,732 Added 31.66%
44,634 $3.17 Million
Q2 2022

Jul 18, 2022

SELL
$72.62 - $79.98 $50,398 - $55,506
-694 Reduced 2.01%
33,902 $2.62 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $1.11 Million - $1.33 Million
18,078 Added 109.44%
34,596 $2.53 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $59,797 - $69,709
1,115 Added 7.24%
16,518 $1.02 Million
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $2,909 - $3,168
47 Added 0.31%
15,403 $1.03 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $32,458 - $36,506
547 Added 3.69%
15,356 $969,000
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $131,820 - $149,376
-2,283 Reduced 13.36%
14,809 $919,000
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $138,061 - $152,990
2,404 Added 16.37%
17,092 $879,000
Q2 2020

Jul 20, 2020

SELL
$54.82 - $64.09 $18,035 - $21,085
-329 Reduced 2.19%
14,688 $864,000
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $233,345 - $339,105
5,029 Added 50.35%
15,017 $837,000
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $186,013 - $242,638
3,780 Added 60.89%
9,988 $641,000
Q3 2019

Nov 08, 2019

BUY
$42.77 - $50.71 $12,574 - $14,908
294 Added 4.97%
6,208 $312,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $11,288 - $12,483
-253 Reduced 4.1%
5,914 $268,000
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $180 - $215
4 Added 0.06%
6,167 $294,000
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $300,507 - $389,686
6,163 New
6,163 $320,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.